Recent Company News

• 03:28 PM ET Jan 16, 2026
  

  StreetAccount Summary - Politics of the Market preview: week of 19-Jan

• 02:46 PM ET Jan 16, 2026
  

  Supreme Court grants order to hear appeal of Hikma v Amarin (skinny label case) ($14.93, +0.03)

• 09:20 AM ET Jan 08, 2026
  

  StreetAccount Summary - US Pre-market trading update

• 08:21 AM ET Jan 08, 2026
  

  StreetAccount Summary - US Pre-market trading

• 07:04 AM ET Jan 08, 2026
  

  Amarin Corp. guides Q4 revenue $48-53M vs FactSet $54.6M [3 est, $50.4-62.5M] ($14.03, 0.00)

• 08:55 AM ET Jan 07, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 06:04 PM ET Jan 06, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 04:15 PM ET Jan 06, 2026
  

  Shares of Ventyx Biosciences continue higher in after-hours

• 12:00 PM ET Dec 29, 2025
  

  StreetAccount Summary - U.S. Unusual Option Volume: VIX +7.7% to $14.64; S&P 500 (0.4%) to $6,901.54

• 09:09 AM ET Oct 29, 2025
  

  Transcript Intelligence: Amarin Corp. Q3 Earnings Guidance ($18.94, 0.00)